Directive - General
Direktif untuk semua produk yang mengandungi filgrastim dan pegfilgrastim: Amaran berkaitan risiko capillary leak syndrome (CLS) bagi pesakit kanser dan healthy donor (filgrastim) dan bagi pesakit kanser (pegfilgrastim)
Written by Choo Sim Mei · 24 September 2014
Document not available
The file for this publication is not currently available online. Contact NPRA if you need a copy.